Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
The VELscope is a visualization-enhancement adjunct currently marketed to assist the clinician in assessing potentially dysplastic or malignant mucosal lesions in the oral cavity. The author examined 130 subjects, who smoked at least one package of cigarettes per day. The clinical findings derived from a conventional examination protocol were compared to the findings observed with the VELscope. Ten suspicious lesions were identified by conventional examination. No occult suspicious lesions were identified using the VELscope. VELscope interpretation did not enhance or otherwise alter the clinical management of the suspicious lesions. Several commonly occurring conditions, such as mucosal pigmentations, ulcerations, irritations, and gingivitis were associated with a loss of fluorescence using VELscope. The findings of this study raise questions concerning the utilization of the VELscope as a screening adjunct.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!